OUR WHY
Autism innovation.
We’re modernizing Applied Behavior Analysis with tools and insights for better care and long-term success.
THE OPPORTUNITY
Improve ABA
Applied Behavior Analysis is the gold-standard therapy to help those with autism achieve their best possible outcome towards independent living, meaningful relationships, lifelong vocation and self-advocacy.
But challenges persist:
SPECTRUMAI
We’re improving the quality of ABA therapy with objective data, meaningful insights and actionable nudges. We partner with provider and payor organizations to establish value-based contracting models.
OUR FOUNDER & CEO
Ling Shao’s Story
Ling’s own journey to help all four of her boys diagnosed with autism get the care they needed led her to found SpectrumAi, to modernize and democratize access to high-quality ABA therapy for kids on the spectrum everywhere.
LinkedIn
Investors
“SpectrumAi is uniquely positioned, and now well-capitalized, to progress ABA therapy to address a major unmet need in autism care. We look forward to supporting Ling Shao and the rest of their team as they advance the company into the next phase.”
Carl Byers
Partner, F-Prime Capital
Investors
“Autism advocates and parents of autistic children have made enormous strides to get all 50 states to mandate coverage of ABA therapy. But when we took a closer look at the industry, there have been a very limited number of investments that focus on quality in the space. The emphasis on quality is the key to better outcomes for families and a chance for autistic children to grow into their full potential.”
Former U.S. Senator Bill Frist, M.D.
Co-founder of Frist Cressey
Investors
“As the investment and innovation arm of the autism community, Autism Impact Fund believes strongly in SpectrumAI’s model, which will lead to improved outcomes through disruptive technology and value based care.”
Chris Male
Autism Impact Fund’s Co-Founder and Managing Partner.
Investors
“Families, employers and health plans are all frustrated about the quality differential in ABA treatments. We are all willing to pay but would like to get high-quality care in the process. Quality measures do not currently exist in the industry and there is a significant need to evolve towards a pay for quality or pay for value methodology.”
Kent Marquedt
SpectrumAi individual investor and advisor, former CFO of Premera Blue Cross
